Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rubin

Showing results (621-630 of 658) with videos related to

Pageof 66
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 21, 2009
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsyA Cohen, D W Dempster, R Müller, et al.
Nature Medicine|February 12, 2013
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in miceShannon M Reilly, Shian-Huey Chiang, Stuart J Decker, et al.
Molecular Cancer Therapeutics|June 2, 2026
Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck CancersMeghri Katerji, Maxine R Rubin, Eric Lindberg, et al.
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.
The Journal of Clinical Endocrinology and Metabolism|October 8, 2024
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway TrialBart L Clarke, Aliya A Khan, Mishaela R Rubin, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
British Journal of Sports Medicine|July 20, 2007
Hormonal responses to a 160-km race across frozen AlaskaW J Kraemer, M S Fragala, G Watson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 26, 2022
Management of HypoparathyroidismAliya A Khan, Gordon Guyatt, Dalal S Ali, et al.
Advances in Therapy|May 1, 2024
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway TrialLars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway TrialAliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
Pageof 66

Showing results (621-630 of 658) with videos related to

Sort By:
Pageof 66
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 21, 2009
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsyA Cohen, D W Dempster, R Müller, et al.
Nature Medicine|February 12, 2013
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in miceShannon M Reilly, Shian-Huey Chiang, Stuart J Decker, et al.
Molecular Cancer Therapeutics|June 2, 2026
Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck CancersMeghri Katerji, Maxine R Rubin, Eric Lindberg, et al.
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.
The Journal of Clinical Endocrinology and Metabolism|October 8, 2024
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway TrialBart L Clarke, Aliya A Khan, Mishaela R Rubin, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
British Journal of Sports Medicine|July 20, 2007
Hormonal responses to a 160-km race across frozen AlaskaW J Kraemer, M S Fragala, G Watson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 26, 2022
Management of HypoparathyroidismAliya A Khan, Gordon Guyatt, Dalal S Ali, et al.
Advances in Therapy|May 1, 2024
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway TrialLars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway TrialAliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
Pageof 66